On the heels of UFC President Dana White expressing his confidence in hopefully getting Cris Cyborg cleared of her potential USADA anti-doping violation stemming from an out of competition drug test in December of 2016, the news has been made official.
A statement was released on Cyborg being cleared, which partly read:
Under the UFC TUE Policy, to receive approval of a TUE, athletes must submit medical records demonstrating a verifiable medical diagnosis and legitimate medical need for the requested medication in accordance with the applicable WADA guidelines. At least two members of USADA’s independent TUE Committee (TUEC) – comprised of medical experts with various areas of expertise from around the U.S. – must individually review the TUE application, after which a recommendation is made to USADA as to whether the TUE should be granted or denied.
In the case of Justino, the application for a TUE was granted because the athlete had an unequivocally diagnosed chronic medical condition for which the use of Spironolactone is the appropriate standard of care. Further, it was determined that the athlete and her medical team pursued and exhausted all non-prohibited alternatives and that the low dose of the medication is consistent with best medical practice to treat her condition and would return the athlete to a normal state of health without providing a performance-enhancing benefit.
Because Justino’s TUE application was granted retroactively, her provisional suspension has been lifted with immediate effect and her positive test will not result in an anti-doping policy violation. However, as a condition of the TUE approval, Justino will be required to continue to carefully document her medical care and must apply for a TUE renewal in advance of TUE expiry should she wish to maintain compliance with the UFC Anti-Doping Policy.
With Cyborg now cleared of wrongdoing and eligible to fight again, expect major news regarding Cyborg’s place in the title picture in the women’s featherweight division.
This article first appeared on BJPenn.com on 2/17/2017.This article appeared first on BJPENN.COM